Wang et al.27 showed that BRD4 was significantly upregulated in pancreatic cancer cell lines and that BRD4 promoted cell proliferation and gemcitabine resistance in pancreatic cancer. This evidence concerns the gene BRD4 and familial pancreatic carcinoma.